Doxorubicin Synergizes with 34.5ENVE to Enhance Antitumor Efficacy against Metastatic Ovarian CancerChelsea Bolyard, Balveen Kaur, Jianying Zhang et al.|Clinical Cancer Research|2014Cited by 32
Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor ImmunityBangxing Hong, Balveen Kaur, Guangan He et al.|Clinical Cancer Research|2020Cited by 28
Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virusUksha Saini, Karuppaiyah Selvendiran, Brentley Q. Smith et al.|Journal of Ovarian Research|2022Cited by 9
Correction: Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virusUksha Saini, Karuppaiyah Selvendiran, Brentley Q. Smith et al.|Journal of Ovarian Research|2023Cited by 0
Data from Doxorubicin Synergizes with 34.5ENVE to Enhance Antitumor Efficacy against Metastatic Ovarian CancerChelsea Bolyard, Balveen Kaur, Ji Young Yoo et al.|Unknown|2023Cited by 0